close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Metagenomi, Inc. - Common Stock (NQ:MGX)

1.770 +0.215 (+13.83%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Metagenomi, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
Enhances strategic flexibility and control of key gene editing technologies and programs 
From Metagenomi, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Metagenomi to Present at Upcoming Scientific Meetings
From Metagenomi, Inc.
Via GlobeNewswire
News headline image
Metagenomi Reports Business Updates and Full Year 2023 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
News headline image
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
From Metagenomi Technologies, LLC
Via GlobeNewswire
News headline image
This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet ↗
A bumpy start can't detract from this company's strong balance sheet. 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Metagenomi Announces Closing of Initial Public Offering
From Metagenomi Technologies, LLC
Via GlobeNewswire
News headline image
Gilead-Backed Kyverna Overshoots Raised IPO Expectations ↗
Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a... 
Via Talk Markets
Topics Initial Public Offering
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today